Athersys (ATHX) Peer Comparison

$0.01

$-0.02 (-72.34%)

As on 11-Mar-2024 09:30EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

219.6

Div. Yield

0 %

Edit

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Market cap ($ Mln)	1	15
Revenue ($ Mln)	0	1
Net Profit ($ Mln)	-42.10	-10.29
Net Margin (%)	-37,256.64	-753.92
RoE (%)	--	-57.28
Price to Earnings	--	--
Price-To-Book	219.57	0.69

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Operating Revenue	0.11	0.65
Cost of Revenue	0.00	2.60
Gross Profit	5.33	-0.82
Operating Expenses	48.20	17.54
Operating Profit (EBIT)	-48.09	-11.38
Other Income	0.00	0.00
Profit before Tax	-42.70	-10.29
Provision for Tax	-0.60	-5.27
Profit after Tax (Net Income)	-42.10	-4.91
Minority Interest	0.00	0.00
Consolidated Profit	-38.77	-8.74

Liabilities ($ Mln)

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Shareholder's Funds	-36.40	14.11
Minority Interest	0.00	0.00
Non-Current Liabilities	5.20	1.78
Current Liabilities	38.62	4.51
Total Liabilities	27.73	47.49

Assets ($ Mln)

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Non-Current Assets	5.20	8.84
Current Assets	2.23	11.56
Total Assets	27.73	47.49
Total Debt*	18.58	0.00
Net Current Assets	-36.39	7.04

Cashflow ($ Mln)

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Cash From Operating Activities	-58.95	-28.33
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	30.84	-0.51
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
ROCE (%)	-1,161.95	638.22
ROE (%)	1,819.33	-40.03
ROA (%)	-69.98	-11.39
EBIT Margin (%)	-30,412.39	-1,089.86
Net Margin (%)	-37,256.64	-753.92
Cash Profit Margin (%)	-0.04	0.00

Growth Ratios

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Revenue Growth (%)	-98.12	-63.24
EBIT Growth (%)	59.58	-113.43
Net Profit Growth (%)	45.63	-110.21
EPS Growth (%)	70.11	-103.95
Book Value Growth (%)	-6.04	-71.75

Valuation Ratios

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Price / Earnings	-0.22	0.35
Price / Book Value	-0.63	0.77
Dividend Yield (%)	--	--
EV/EBITDA	-0.21	-0.38
Market Cap ($ Cr)	--	--

Solvency Ratios

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	-0.51	0.00
Current Ratio	0.06	2.56
Quick Ratio	0.06	2.56
Interest Coverage	-70.52	-16.89

Operating Efficiency Ratios

	Athersys (ATHX)	AcelRx Pharmaceuticals (ACRX)
Debtors to sales (%)	0.00	0.00
Asset Turnover	0.00	0.02
Receivable days	175.94	48.36
Inventory Days	--	161.34
Payable days	--	293.29
Cash Conversion Cycle	--	-83.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly